cataract
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) above 18 years old, male or female; 2) Patients with cataract who are expected to undergo cataract phacoemulsification + IOL implantation have a hardness of 1 to 3 in the surgical eye nucleus; 3) Eye surgery is expected to correct intraocular lens refraction in the -10.0D to +36.0D; 4) To be able to understand the purpose of the trial, voluntarily participate in and sign the informed consent form either by the patient or his legal guardian.
Exclusion criteria
Exclusion criteria: 1) ophthalmology combined with other eye diseases, contraindications for implantation of intraocular lenses such as small or large eyeballs, malignant glaucoma, severe corneal dystrophy, uncontrollable over-pressure, excessive macular / pigment Epithelial cell disease, diabetic retinopathy, severe optic nerve atrophy, massive vitreous loss, chronic uveitis, severe anterior chamber superficial, choroidal hemorrhage, posterior capsular rupture or ciliary band separation (intraocular lens fixation), color vision Defects, macular degeneration or cystoid edema and other serious ocular diseases associated; 2) those with severe or unstable heart, liver, kidney, lung, endocrine (including thyroid insufficiency), blood, mental disorders; 3) surgery eyes had retinal detachment or retinopathy; 4) surgery eye traumatic cataract or congenital bilateral cataract patients; 5) electrocardiogram or laboratory test results suggest that surgical contraindications; 6) unattended or unable to follow the doctor's advice; 7) Eye surgery nearly 3 months had eye injury or intraocular surgery history; 8) who need eye joint surgery; 9) Participate in other drug or medical device clinical trials within 30 days prior to screening; 10) Patients in need of eye or systemic medication that may affect vision during use or study; 11) Pregnant or lactating women; 12) the researchers judged the contralateral eye ignores the function; 13) Diabetic patients; 14) Other conditions in which the researcher judges that the patient is unsuitable for inclusion.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| vision; | — |
Contacts
Capital Medical University Affiliated Beijing Tong